Methods Number of Prescriptions and Gross Spending Data: This analysis uses 2019 through 2024 State Drug Utilization Data (SDUD) (downloaded in January 2026)
Over the next few months, well be focusing on: Educating providers on optimizing GLP-1 outcomes Sharing patient success strategies Highlighting the clinical role of dietitians in medical weight management Providing actionable tools to support your patients Our goal is simple: Bridge the gap between medication and meaningful, lasting results
Without the right expertise, companies often end up with brittle integrations, unreliable infrastructure, and compliance gaps that become costly to fix later
The only problem with oral is that it has to be taken on an empty stomach for at least 30 minutes, with minimal water
GLP-1 receptor agonists in alcohol use disorder and alcohol-associated liver disease
If youre asking, Why am I still hungry on semaglutide? Youre not alone